Monique J. Roobol

Monique J. Roobol

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 508 publications

"I think that there is a lack of information and awareness": A PRAISE-U Clinical Trial Update.

"I think that there is a lack of information and awareness": A PRAISE-U Clinical Trial Update.

Journal: European urology focus

Published: July 17, 2026

Cancer detection in the European Randomised Study of Screening for Prostate Cancer (ERSPC).

Cancer detection in the European Randomised Study of Screening for Prostate Cancer (ERSPC).

Journal: BJU international

Published: July 04, 2026

Prostate Cancer Mortality in Men not Attending a Population-based Screening Program: The 'Good', the 'Bad', and the 'Ugly' After 20-yr Follow-up in the European Randomised study of Screening for Prostate Cancer.

Prostate Cancer Mortality in Men not Attending a Population-based Screening Program: The 'Good', the 'Bad', and the 'Ugly' After 20-yr Follow-up in the European Randomised study of Screening for Prostate Cancer.

Journal: European urology open science

Published: June 14, 2026

The Prognostic Value of Baseline PSA Density on Long-term Oncological Outcomes in Men with an Initial Negative Prostate Biopsy: Results from ERSPC Rotterdam.

The Prognostic Value of Baseline PSA Density on Long-term Oncological Outcomes in Men with an Initial Negative Prostate Biopsy: Results from ERSPC Rotterdam.

Journal: European urology open science

Published: June 10, 2026

Prediction models for adverse events from prostate cancer curative radiotherapy: a systematic review of methodological quality.

Prediction models for adverse events from prostate cancer curative radiotherapy: a systematic review of methodological quality.

Journal: Translational oncology

Published: June 08, 2026

Screening for prostate cancer; a screening program is favored over current opportunistic testing

Screening for prostate cancer; a screening program is favored over current opportunistic testing

Journal: Nederlands tijdschrift voor geneeskunde

Published: June 02, 2026

Improved prostate cancer grading by incorporating Gleason pattern quantification, invasive cribriform and intraductal carcinoma in the new QUICC-score.

Improved prostate cancer grading by incorporating Gleason pattern quantification, invasive cribriform and intraductal carcinoma in the new QUICC-score.

Journal: Annals of diagnostic pathology

Published: May 15, 2026

From Evidence to Implementation: How Should We Screen for Prostate Cancer in the Modern Era?

From Evidence to Implementation: How Should We Screen for Prostate Cancer in the Modern Era?

Journal: European urology

Published: April 29, 2026

Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.

Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.

Journal: European urology

Published: March 23, 2026

Empowering choices: insights from healthcare professionals on shared decision-making in kidney cancer.

Empowering choices: insights from healthcare professionals on shared decision-making in kidney cancer.

Journal: BJU international

Published: March 17, 2026

Who, When, and How: Watchful Waiting in the ERSPC Rotterdam.

Who, When, and How: Watchful Waiting in the ERSPC Rotterdam.

Journal: European urology open science

Published: March 12, 2026

Prostate cancer mortality among men with and without comorbidity: Long-term results from the European randomized study of screening for prostate cancer Rotterdam.

Prostate cancer mortality among men with and without comorbidity: Long-term results from the European randomized study of screening for prostate cancer Rotterdam.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 30, 2026

Showing 1-12 of 508

Last Updated: 09/26/2026